The delisting risk from the bid price deficiency is now resolved, removing a key overhang for TNON. Monitor the next quarterly filing for revenue and cash runway updates, as the company's $5M market cap and pre-revenue status remain the primary fundamental risks.
Price Chart
Executive Summary
Tenon Medical filed an 8-K announcing it received written confirmation from Nasdaq that it has regained compliance with the minimum bid price requirement (Rule 5550(a)(2)) following a 1-for-35 reverse stock split effective August 10, 2026. The Nasdaq bid price deficiency matter is now closed, removing the immediate delisting risk for TNON common stock. This is a routine compliance update with no financial data or operational changes reported.
Key Facts
- Tenon Medical received Nasdaq written confirmation on August 24, 2026 that it regained compliance with the minimum bid price requirement under Listing Rule 5550(a)(2).
- The compliance was achieved after a 1-for-35 reverse stock split effective August 10, 2026, with the closing bid price at $1.00 or greater for 10 consecutive business days.
- The Nasdaq bid price deficiency matter is now closed, and the common stock continues to trade on the Nasdaq Capital Market under symbol TNON.
- No financial data, revenue, earnings, or operational updates were provided in this filing.
Financial Impact
No financial figures reported in the filing. The reverse stock split and compliance regain have no direct financial impact disclosed.
Risk Factors
- The company has a $5M market cap and is a pre-revenue medical device company with limited operating history, making it highly speculative.
- The reverse stock split may reduce liquidity and increase volatility, and the stock could face renewed bid price pressure if fundamentals do not improve.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (TNON) — Batch item 1 | 0001213900-26-092944 |
| Document: 0001213900-26-092944-index.html | 0001213900-26-092944 |
| Document: 0001213900-26-092944.txt | 0001213900-26-092944 |
| 8-K Filing (TNON) — Batch item 4 | 0001213900-26-092944 |
| Document: 0001213900-26-092944-index.html | 0001213900-26-092944 |
| Document: 0001213900-26-092944.txt | 0001213900-26-092944 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 8-K | $2.20 | awaiting T+20 | — | $2.15 (−2.05%) |
Oct 16, 2026 10d ago | 424B5 | $2.45 | awaiting T+20 | — | $2.15 (+12.04%) |
Oct 13, 2026 13d ago | EFFECT | $2.89 | awaiting T+20 | — | $2.15 (+25.43%) |
Oct 9, 2026 17d ago | 3 | $2.98 | awaiting T+20 | — | $2.15 (−27.68%) |
Sep 16, 2026 5w ago | 8-K | $4.20 $2.91 | ▲ +30.71% | ▲ +31.92% | $2.15 (+48.69%) |
Sep 11, 2026 6w ago | Insider Buy | $5.93 $3.41 | ▼ −42.50% | ▼ −44.36% | $2.15 (−63.66%) |
Sep 9, 2026 6w ago | 8-K | $2.44 $3.50 | ▲ +43.44% | ▲ +41.50% | $2.15 (−11.68%) |
Sep 1, 2026 7w ago | Insider Buy | $4.47 $4.04 | ▲ +9.62% | ▲ +9.71% | $2.15 (+51.79%) |
Aug 31, 2026 8w ago | 8-K | $4.53 $2.73 | ▲ +39.74% | ▲ +39.55% | $2.15 (+52.43%) |
Aug 31, 2026 8w ago | 3 | $4.53 $2.73 | ▼ −39.74% | ▼ −39.55% | $2.15 (−52.43%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers